• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在猪冠状动脉模型中植入依维莫司洗脱可吸收血管支架 1 个月、2 个月、3 个月和 4 年后的冠状动脉内光学相干断层成像和组织学:尝试解读 ABSORB 试验中的人类光学相干断层成像图像。

Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial.

机构信息

Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.

出版信息

Circulation. 2010 Nov 30;122(22):2288-300. doi: 10.1161/CIRCULATIONAHA.109.921528. Epub 2010 Oct 25.

DOI:10.1161/CIRCULATIONAHA.109.921528
PMID:20975003
Abstract

BACKGROUND

With the use of optical coherence tomography (OCT), alterations of the reflectance characteristics of everolimus-eluting bioresorbable vascular scaffold (BVS) struts have been reported in humans. In the absence of histology, the interpretation of the appearances of the struts by OCT remains speculative. We therefore report OCT findings with corresponding histology in the porcine coronary artery model immediately after and at 28 days and 2, 3, and 4 years after BVS implantation.

METHODS AND RESULTS

Thirty-five polymeric BVS (3.0×12.0 mm) were singly implanted in the main coronary arteries of 17 pigs that underwent OCT and were then euthanized immediately (n=2), at 28 days (n=2), at 2 years (n=3), at 3 years (n=5), or at 4 years (n=5) after implantation. All BVS-implanted arteries in these animals were evaluated by histology except for 5 arteries examined at 2 years with gel permeation chromatography to assess the biodegradation of the polymeric device. Fourteen arteries with BVS from an additional 6 pigs were examined by gel permeation chromatography at 1 (n=1), 1.5 (n=2), and 3 (n=2) years. Corresponding OCT and histology images were selected with the distal and proximal radiopaque markers used as landmarks. At 28 days, by OCT, 82% of struts showed sharply defined, bright reflection borders, best described as a box-shaped appearance. Histologically, all struts appeared intact with no evidence of resorption. At 2 years, by OCT, 60±20 struts were discernible per BVS with 80.4% of the strut sites as a box-shaped appearance. Despite their defined appearance by OCT, by histology, these structures appeared to be composed of proteoglycan, with polymeric material being at such low level as to be no longer quantifiable by chromatography. At 3 years, by OCT, recognizable struts decreased to 28±9 struts per BVS: 43.7% showed dissolved black box; 34.8%, dissolved bright box; 16.1%, open box; and 5.4%, preserved box appearance. Histology shows that connective tissue cells within a proteoglycan-rich matrix replaced the areas previously occupied by the polymeric struts and coalesced into the arterial wall. At 4 years, by OCT, 10±6 struts were recognizable as either dissolved black or dissolved bright box. In histology, these struts are minimally discernible as foci of low-cellular-density connective tissue. Relative to the prediction of histological type by OCT appearance, the preserved box appearance of OCT corresponds well with 2-year histology (86.4%), whereas the dissolved bright and black box appearances correspond to 3-year histology (88.0% and 90.7%, respectively). Struts indiscernible by OCT correspond to the integrated strut footprints seen at 4 years (100%).

CONCLUSIONS

Struts that are still discernible by OCT at 2 years are compatible with largely bioresorbed struts, as demonstrated by histological and gel permeation chromatography analysis. At 3 and 4 years, both OCT and histology confirm complete integration of the struts into the arterial wall.

摘要

背景

利用光相干断层扫描(OCT),已经在人体中报告了依维莫司洗脱的生物可吸收血管支架(BVS)支架的反射率特征的变化。在没有组织学的情况下,OCT 对支架外观的解释仍然是推测性的。因此,我们报告了在猪冠状动脉模型中即刻植入 BVS 后以及植入后 28 天、2 年、3 年和 4 年的 OCT 发现,并与相应的组织学结果相对应。

方法和结果

17 只猪的主冠状动脉中单独植入了 35 个聚合物 BVS(3.0×12.0mm),在植入后立即(n=2)、28 天(n=2)、2 年(n=3)、3 年(n=5)和 4 年(n=5)时进行了 OCT 和安乐死。这些动物中除了 5 个在 2 年时用凝胶渗透色谱法检查以评估聚合物装置的生物降解情况外,所有植入 BVS 的动脉都进行了组织学检查。另外 6 只猪的 14 个动脉用凝胶渗透色谱法在 1(n=1)、1.5(n=2)和 3(n=2)年后进行了检查。选择具有远端和近端不透射线标记物的相应 OCT 和组织学图像作为标记。在 28 天时,通过 OCT,82%的支架显示出清晰的、明亮的反射边界,最好描述为盒形外观。组织学上,所有支架均完整,无吸收迹象。在 2 年时,通过 OCT,每个 BVS 可识别 60±20 个支架,80.4%的支架部位呈盒形外观。尽管 OCT 显示其外观清晰,但组织学上这些结构似乎由糖胺聚糖组成,聚合物材料的水平如此之低,以至于无法通过色谱法进行定量。在 3 年时,可识别的支架减少到每个 BVS 28±9 个:43.7%显示溶解的黑色盒;34.8%,溶解的明亮盒;16.1%,打开的盒;5.4%,保留盒外观。组织学显示,富含糖胺聚糖的基质中的结缔组织细胞取代了以前由聚合物支架占据的区域,并融合到动脉壁中。在 4 年时,通过 OCT 可识别 10±6 个支架,呈溶解的黑色或溶解的明亮盒。组织学上,这些支架作为低细胞密度结缔组织的焦点难以辨认。相对于 OCT 外观对组织学类型的预测,OCT 的保留盒外观与 2 年的组织学很好地吻合(86.4%),而溶解的明亮和黑色盒外观与 3 年的组织学吻合(分别为 88.0%和 90.7%)。OCT 无法识别的支架与 4 年时观察到的集成支架足迹相对应(100%)。

结论

在 2 年时仍可通过 OCT 识别的支架与组织学和凝胶渗透色谱分析显示的大部分生物吸收支架一致。在 3 年和 4 年时,OCT 和组织学都证实支架完全整合到动脉壁中。

相似文献

1
Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial.在猪冠状动脉模型中植入依维莫司洗脱可吸收血管支架 1 个月、2 个月、3 个月和 4 年后的冠状动脉内光学相干断层成像和组织学:尝试解读 ABSORB 试验中的人类光学相干断层成像图像。
Circulation. 2010 Nov 30;122(22):2288-300. doi: 10.1161/CIRCULATIONAHA.109.921528. Epub 2010 Oct 25.
2
Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice.猪冠状动脉模型中重叠依维莫司洗脱可吸收血管支架的冠状动脉内光学相干断层成像和组织学:对临床实践的潜在影响。
JACC Cardiovasc Interv. 2013 May;6(5):523-32. doi: 10.1016/j.jcin.2012.12.131.
3
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).植入可吸收依维莫司洗脱完全生物可吸收血管支架后急性支架断裂和晚期结构不连续性的发生率和影像学结果:ABSORB 队列 B 试验的光学相干断层成像评估(生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变患者的临床评价)。
JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016.
4
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.第二代生物可吸收依维莫司药物洗脱血管支架治疗冠状动脉原发狭窄的临床和影像学 6 个月随访结果。
Circulation. 2010 Nov 30;122(22):2301-12. doi: 10.1161/CIRCULATIONAHA.110.970772. Epub 2010 Nov 15.
5
Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies.在健康猪冠状动脉模型中植入后两年,应用体内光学相干断层扫描和组织学评价依维莫司洗脱的生物可吸收血管支架的血管效应:对未来临床前研究的初步结果的影响。
Int J Cardiovasc Imaging. 2012 Mar;28(3):499-511. doi: 10.1007/s10554-011-9860-z. Epub 2011 Apr 19.
6
In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis.采用高斯线扩散函数分析的光学相干断层成像术对生物可吸收血管支架支柱界面的体内特性进行研究。
EuroIntervention. 2012 Feb;7(10):1227-35. doi: 10.4244/EIJV7I10A195.
7
Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds--an optical coherence tomography substudy of the EVERBIO II trial.依维莫司洗脱冠状动脉支架和生物雷帕霉素洗脱冠状动脉支架与依维莫司洗脱生物可吸收支架的血管反应——EVERBIO II试验的光学相干断层扫描子研究
Swiss Med Wkly. 2016 Jan 14;146:w14274. doi: 10.4414/smw.2016.14274. eCollection 2016.
8
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes.第二代生物可吸收依维莫司洗脱血管支架治疗初发冠状动脉狭窄的评估:12 个月临床和影像学结果。
J Am Coll Cardiol. 2011 Oct 4;58(15):1578-88. doi: 10.1016/j.jacc.2011.05.050.
9
OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold.经皮冠状动脉介入治疗后 5 年的依维莫司洗脱生物可吸收血管支架的长期血管愈合反应的 OCT 评估。
J Am Coll Cardiol. 2014 Dec 9;64(22):2343-56. doi: 10.1016/j.jacc.2014.09.029. Epub 2014 Dec 1.
10
Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model.在猪冠状动脉模型中,依维莫司洗脱可吸收血管支架和钴铬依维莫司洗脱 XIENCE V 支架的长期安全性。
Circ Cardiovasc Interv. 2014 Jun;7(3):330-42. doi: 10.1161/CIRCINTERVENTIONS.113.000990. Epub 2014 Jun 3.

引用本文的文献

1
Absorb® bioresorbable scaffold in "established" versus "off-label" coronary lesions: 5-year data from the GABI-R® registry.“已确立适应证”与“超适应证”冠状动脉病变中Absorb®生物可吸收支架的应用:来自GABI-R®注册研究的5年数据
Clin Res Cardiol. 2025 Aug;114(8):1084-1094. doi: 10.1007/s00392-025-02707-3. Epub 2025 Jun 30.
2
A novel iron bioresorbable scaffold: a potential strategy for pulmonary artery stenosis.一种新型铁可生物吸收支架:肺动脉狭窄的潜在治疗策略。
Regen Biomater. 2025 May 13;12:rbaf041. doi: 10.1093/rb/rbaf041. eCollection 2025.
3
Application of optical coherence tomography in cardiovascular diseases: bibliometric and meta-analysis.
光学相干断层扫描在心血管疾病中的应用:文献计量学与荟萃分析
Front Cardiovasc Med. 2024 Jul 9;11:1414205. doi: 10.3389/fcvm.2024.1414205. eCollection 2024.
4
Long-term efficacy, safety and biocompatibility of a novel sirolimus eluting iron bioresorbable scaffold in a porcine model.新型西罗莫司洗脱铁生物可吸收支架在猪模型中的长期疗效、安全性及生物相容性
Bioact Mater. 2024 May 18;39:135-146. doi: 10.1016/j.bioactmat.2024.05.027. eCollection 2024 Sep.
5
Safety and efficacy of a novel 3D-printed bioresorbable sirolimus-eluting scaffold in a porcine model.新型3D打印生物可吸收西罗莫司洗脱支架在猪模型中的安全性和有效性
AsiaIntervention. 2023 Sep 21;9(2):133-142. doi: 10.4244/AIJ-D-22-00051. eCollection 2023 Sep.
6
Thrombosis and myocardial infarction: the role of bioresorbable scaffolds.血栓形成与心肌梗死:生物可吸收支架的作用
J Cardiovasc Aging. 2023 Feb;3(1). doi: 10.20517/jca.2022.41. Epub 2023 Jan 1.
7
Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice.在真实世界实践中,依维莫司洗脱可降解血管支架与第二代药物洗脱支架的安全性和疗效。
J Korean Med Sci. 2023 Feb 6;38(5):e34. doi: 10.3346/jkms.2023.38.e34.
8
Saphenous vein graft intervention with a bioresorbable vascular scaffold: a follow-up optical coherence tomography study at 40 months.采用生物可吸收血管支架的大隐静脉移植干预:40个月的光学相干断层扫描随访研究
AsiaIntervention. 2019 Feb 20;5(1):27-31. doi: 10.4244/AIJ-D-18-00020. eCollection 2019 Feb.
9
The endothelium permeability after bioresorbable scaffolds implantation caused by the heterogeneous expression of tight junction proteins.生物可吸收支架植入后,紧密连接蛋白的异质性表达导致内皮细胞通透性增加。
Mater Today Bio. 2022 Aug 27;16:100410. doi: 10.1016/j.mtbio.2022.100410. eCollection 2022 Dec.
10
Clinical Results of Drug-Coated Balloon Treatment in a Large-Scale Multicenter Korean Registry Study.韩国一项大规模多中心注册研究中药物涂层球囊治疗的临床结果
Korean Circ J. 2022 Jun;52(6):444-454. doi: 10.4070/kcj.2021.0261. Epub 2022 Mar 15.